In this episode, host Chad Bowne and guest Tom Boyke dissect the Trump administration’s new pharmaceutical tariffs and the U.S.-U.K. pricing arrangement, explaining how they aim to address two distinct challenges: low‑margin generic drug shortages tied to China and India, and sky‑high prices for patented branded medicines. Boyke highlights that U.S. generics suffer from supply fragility, while branded drugs are costly because the U.S. lacks a centralized negotiating purchaser like the U.K.’s NHS. The administration’s strategy uses trade tools—Section 232 tariffs and bilateral deals—to pressure foreign producers and secure reshoring commitments, but the episode questions whether these moves will actually lower U.S. prices or improve supply security.
In this episode of the Facts and Fallacies podcast, hosts Cameron English and Dr. Liza Lockwood dissect the rapid evolution of illicit opioids, likening it to microbial drug resistance. They explain how prohibition drives black‑market producers to splice ever‑more potent...
In this episode, host Stuart Ralph talks with Dr. Saoirse O'Connor, a neuroscientist who led the PsilOCD study—the first controlled European trial of low‑dose psilocybin for obsessive‑compulsive disorder. The conversation covers the science of psilocybin, the study design (a 10 mg...

In this episode, Dr. Michelle Jorgensen, a holistic dentist, explains how oral health—particularly mercury‑containing fillings, hidden infections, and airway obstruction—can drive inflammation and compromise sleep quality, leading to issues like bruxism and sleep apnea. She shares her personal journey from...
In this episode of CareTalk, John Driscoll speaks with Spencer Pratt, Chief Growth Officer of NourishedRx, about the company’s digital health platform that uses clinically‑guided food delivery, tele‑nutrition counseling, and digital coaching to treat diet‑related chronic diseases. Pratt explains how...

The episode follows Reiley, who grew up on a massive cattle station in Western Australia, detailing his rugged, independent childhood and early work as an electrician before transitioning to strength‑and‑conditioning coaching. He recounts a harrowing COVID‑19 experience in Brazil in...
In this DDW podcast episode, host Bruno Quinney discusses two recent DDW articles: one on the urgent need to combat antimicrobial resistance (AMR) with insights from Professor Janet Hemingway, and another on the rapid expansion of mRNA therapeutics. Hemingway highlights...
In this episode, Dr. Bob Jarvie, Associate CMIO and Medical Director for Population Health Analytics at Corewell Health, explains why the health system built its own internal population health data platform instead of relying on external vendors. He highlights the...

The episode delves into the controversy surrounding the FDA’s handling of hydroxychloroquine during the COVID‑19 pandemic, focusing on whistleblower Dr. Rick Bright’s claims that Dr. Janet Woodcock pressured him to pursue an Emergency Use Authorization (EUA) rather than an expanded‑access protocol....

In this episode of Business Game Changers, host Sarah Westall and Dr. Diane Kayser discuss the rapidly evolving peptide market, focusing on the upcoming weight‑loss peptide retatrutide (also called Reditrutide). They explain how big‑pharma is moving to control peptide supplements,...

In this episode, senior fellow Jessica Rose discusses her forthcoming paper on the shortcomings of the U.S. Vaccine Adverse Event Reporting System (VAERS) and proposes a modernization framework. She highlights structural issues such as poor data quality, under‑reporting, lack of...

In this episode, Unity Stokes talks with Kim Fisher, Chief Impact Officer of Startup Health’s Food is Medicine Moonshot and Program Director of UC Davis’s Innovation Institute for Food and Health, about the rapid emergence of the food‑as‑medicine movement. Fisher...

In this episode of American Sunrise, Dr. Peter McCullough critiques recent attempts by Robert F. Kennedy Jr. and the CDC to reduce the U.S. childhood vaccine schedule, arguing that the process excluded major medical societies and was therefore legally vulnerable. He contends that the...

In this live episode of Healthcare Headlines, hosts Mike and his co‑host review the rapidly evolving benefits landscape, tracing it from the simple formulary decisions of 20 years ago to today’s complex mix of federal and state legislation, specialty drugs,...

In this episode, Mel Robbins talks with Harvard neurogastroenterologist Dr. Tricia Pasricha about the gut‑brain connection, demystifying what’s normal and abnormal when it comes to digestion, bloating, constipation, and pooping. Dr. Pasricha explains that the gut functions like a second...